CAS RN: 3609-87-8
N-BENZYL 4-BROMOBENZENESULFONAMIDE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251116
1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 3609-87-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
>97%
0
Out of Stock
Hong Kong
Inquiry
3609-87-8 / N-benzyl-4-bromobenzenesulfonamide
Standard CAS: 3609-87-8
Multi CAS: Yes
Basic Information
copy
CAS
3609-87-8 copy
Multi CAS
Yes copy
Molecular Formula
BC13H12O2RnS copy
Molecular Weight
326.210000 copy
Exact Mass
324.977210 copy
InChI
InChI=1S/C13H12BrNO2S/c14-12-6-8-13(9-7-12)18(16,17)15-10-11-4-2-1-3-5-11/h1-9,15H,10H2 copy
InChIKey
KBFYMIDQZWIKJR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.08 copy
Rotatable bonds
4 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
74.61 copy
TPSA
46.17 copy
LogP / Solubility
WLOGP
2.93 copy
MLOGP
2.59 copy
XLogP3
3.1 copy
Consensus LogP
2.87 copy
Log S (ESOL)
-3.94 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.35 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.69 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.63 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy